![Palle Christophersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Palle Christophersen
Oprichter bij
SANA AB
Profiel
Palle Christophersen is the founder of Cephagenix ApS, founded in 2020, and Saniona AB, founded in 2011, where the title held is Executive Vice President-Research.
The current job is Chief Scientific Officer at Saniona A. Former job includes Vice President & Director-Vitro Pharmacology at NTG Nordic Transport Group A from 1991 to 2012.
Education includes a doctorate from the University of Copenhagen.
Actieve functies van Palle Christophersen
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA AB | Oprichter | 01-01-2011 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Palle Christophersen
| Bedrijven | Functie | Einde |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01-01-2012 |
Cephagenix ApS
 Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Oprichter | - |
Opleiding van Palle Christophersen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Health Technology |
